Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (1.239)

2025

  1. Boston Type II Keratoprosthesis, 7 Years of Experience and Outcomes From a Spanish Tertiary Eye Care Hospital

    American Journal of Ophthalmology, Vol. 269, pp. 327-338

  2. Lipid imaging mass spectrometry: Towards a new molecular histology

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1870, Núm. 1

2024

  1. A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis

    JNCI Cancer Spectrum, Vol. 8, Núm. 3

  2. A genome-wide association analysis reveals new pathogenic pathways in gout*

    Nature Genetics

  3. Analysing disease trajectories in a cohort of 71,849 Patients: A visual analytics and statistical approach

    International Journal of Medical Informatics, Vol. 188

  4. Analysis of guideline recommendations for treatment of asthma exacerbations in children: a Pediatric Emergency Research Networks (PERN) study

    Archives of Disease in Childhood, Vol. 109, Núm. 6, pp. 468-475

  5. Anticoagulant and non-anticoagulant therapy in thrombotic antiphospholipid syndrome: old drugs and new treatment targets

    Rheumatology (United Kingdom), Vol. 63, Núm. SI, pp. SI96-SI106

  6. Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease

    npj Parkinson's Disease, Vol. 10, Núm. 1

  7. Autoimmune inflammation triggers aberrant astrocytic calcium signaling to impair synaptic plasticity

    Brain, Behavior, and Immunity, Vol. 121, pp. 192-210

  8. Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus

    Expert Review of Clinical Immunology, Vol. 20, Núm. 4, pp. 359-373

  9. Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia

    Scientific reports, Vol. 14, Núm. 1, pp. 12726

  10. CD151 identifies an NK cell subset that is enriched in COVID-19 patients and correlates with disease severity

    Journal of Infection, Vol. 89, Núm. 6

  11. Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities

    Pediatric Blood and Cancer, Vol. 71, Núm. 8

  12. Characteristics of oncology patients with fever and invasive bacterial infections diagnosed

    Acta Paediatrica, International Journal of Paediatrics

  13. CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in TCF3::PBX1 ALL

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

  14. Clinical Predictors of Mood Disorders and Prevalence of Neuropsychiatric Symptoms in Patients with Systemic Lupus Erythematosus

    Journal of Clinical Medicine, Vol. 13, Núm. 18

  15. Cognitive and brain connectivity trajectories in critically ill COVID-19 patients

    NeuroRehabilitation, Vol. 54, Núm. 3, pp. 359-371

  16. Combined Predictive Model for Endoscopic Third Ventriculostomy Success in Adults and Children

    World Neurosurgery, Vol. 185, pp. e721-e730

  17. Cost-Sensitive Ordinal Classification Methods to Predict SARS-CoV-2 Pneumonia Severity

    IEEE Journal of Biomedical and Health Informatics, Vol. 28, Núm. 5, pp. 2613-2623

  18. Cáncer de cabeza y cuello: revisión del diagnóstico y tratamiento de la sarcopenia

    Nutrición clínica y dietética hospitalaria, Vol. 44, Núm. 3, pp. 80-89